These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15190930)

  • 1. Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney.
    Iguchi T; Nishikawa M; Chang B; Muroya O; Sato EF; Nakatani T; Inoue M
    Free Radic Res; 2004 Apr; 38(4):333-41. PubMed ID: 15190930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.
    Liu L; Song Y; Zhao M; Yi Z; Zeng Q
    Int Urol Nephrol; 2015 Oct; 47(10):1745-52. PubMed ID: 26300162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
    Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
    Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats.
    Sueishi K; Mishima K; Makino K; Itoh Y; Tsuruya K; Hirakata H; Oishi R
    Eur J Pharmacol; 2002 Sep; 451(2):203-8. PubMed ID: 12231392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine.
    Chang B; Nishikawa M; Sato E; Utsumi K; Inoue M
    Arch Biochem Biophys; 2002 Sep; 405(1):55-64. PubMed ID: 12176057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of edaravone against cisplatin-induced chronic renal injury.
    Koike N; Sasaki A; Murakami T; Suzuki K
    Drug Chem Toxicol; 2021 Jul; 44(4):437-446. PubMed ID: 31064223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic efficacy of edaravone in extensively burned rats.
    Koizumi T; Tanaka H; Sakaki S; Shimazaki S
    Arch Surg; 2006 Oct; 141(10):992-5. PubMed ID: 17043277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.
    Satoh M; Kashihara N; Fujimoto S; Horike H; Tokura T; Namikoshi T; Sasaki T; Makino H
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1183-90. PubMed ID: 12649298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury.
    Nakamoto N; Tada S; Kameyama K; Kitamura K; Kurita S; Saito Y; Saito H; Ishii H
    Free Radic Res; 2003 Aug; 37(8):849-59. PubMed ID: 14567445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with edaravone improves the survival rate in renal warm ischemia-reperfusion injury using rat model.
    Matsuyama M; Hayama T; Funao K; Tsuchida K; Takemoto Y; Sugimura K; Kawahito Y; Sano H; Nakatani T; Yoshimura R
    Transplant Proc; 2006 Sep; 38(7):2199-200. PubMed ID: 16980041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
    Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
    Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of edaravone against renal ischemia/reperfusion injury and compared with ischemic postconditioning in rats.
    Li Y; Xia AZ; Xing SH
    Yao Xue Xue Bao; 2010 Jul; 45(7):840-8. PubMed ID: 20931780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
    Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
    Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
    Yagi H; Horinaka S; Matsuoka H
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
    Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.
    Takayasu Y; Nakaki J; Kawasaki T; Koda K; Ago Y; Baba A; Matsuda T
    J Pharmacol Sci; 2007 Apr; 103(4):434-7. PubMed ID: 17409627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
    Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
    Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.